Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
奥拉帕尼联合贝伐单抗作为维持治疗用于新诊断的晚期卵巢癌患者:PAOLA-1/ENGOT-ov25试验的日本亚组
期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2021.32.e82
Fujiwara, Keiichi; Fujiwara, Hiroyuki; Yoshida, Hiroyuki; Satoh, Toyomi; Yonemori, Kan; Nagao, Shoji; Matsumoto, Takashi; Kobayashi, Hiroaki; Bourgeois, Hughes; Harter, Philipp; Mosconi, Anna Maria; Vazquez, Isabel Palacio; Reinthaller, Alexander; Fujita, Tomoko; Rowe, Philip; Pujade-Lauraine, Eric; Ray-Coquard, Isabelle